Long-Term Clinical Benefit to Anti-CCR4 Mogamulizumab: Results from the Phase 3 Mavoric Study in Previously Treated Cutaneous T-Cell Lymphoma (CTCL)
Year: 2018
Type: conference-abstract
Source: Blood
Institutions: Inserm, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, HIPI - Immunologie humaine, physiopathologie et immunithérapie, Lyon 1 Université, Hospices Civils de Lyon, Moffitt Cancer Center, Washington University in St. Louis, Universidad Complutense de Madrid, Research Institute Hospital 12 de Octubre, Hospital Universitario 12 De Octubre, The University of Texas MD Anderson Cancer Center, University of Alabama at Birmingham, Kyowa Kirin (United States), Stanford Medicine
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2906731986